Among adults receiving adalimumab, patients with HS had a greater risk for hospitalization due to infections than patients with PsO.
Every time Jennifer publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback